REGISTERED NUMBER: 06069044 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 January 2026

for

GB Hydrocolloids Limited

Previously known as

David Pengelly Limited

Page

Balance Sheet

1

CALLED UP SHARE CAPITAL NOT PAID

1

1

FIXED ASSETS

1,232

629

CURRENT ASSETS

47,712

61,727

CREDITORS

Amounts falling due within one year

(35,432

)

(40,325

)

NET CURRENT ASSETS

12,280

21,402

TOTAL ASSETS LESS CURRENT LIABILITIES

13,513

22,032

CAPITAL AND RESERVES

13,513

22,032

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

GB Hydrocolloids Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

06069044

Registered office:

Radway

Belle Orchard

Ledbury

Herefordshire

HR8 1DD

The presentation currency of the financial statements is the Pound Sterling (£).

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2025 - 1 ) .

3.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Included within creditors is £140 (2025: £723) owed to the Director of the company, the loans is unsecured, interest free and repayable on demand.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 3 June 2026 and were signed on its behalf by:

D J Pengelly - Director